Baillie Gifford & Co’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-618
| Closed | -$11.6K | – | 297 |
|
|
2023
Q1 | $11.6K | Buy |
618
+74
| +14% | +$1.39K | ﹤0.01% | 386 |
|
|
2022
Q4 | $8.66K | Hold |
544
| – | – | ﹤0.01% | 421 |
|
|
2022
Q3 | $9K | Hold |
544
| – | – | ﹤0.01% | 415 |
|
|
2022
Q2 | $8K | Hold |
544
| – | – | ﹤0.01% | 428 |
|
|
2022
Q1 | $13K | Hold |
544
| – | – | ﹤0.01% | 414 |
|
|
2021
Q4 | $13K | Hold |
544
| – | – | ﹤0.01% | 420 |
|
|
2021
Q3 | $9K | Hold |
544
| – | – | ﹤0.01% | 452 |
|
|
2021
Q2 | $13K | Hold |
544
| – | – | ﹤0.01% | 401 |
|
|
2021
Q1 | $14K | Buy |
544
+12
| +2% | +$309 | ﹤0.01% | 367 |
|
|
2020
Q4 | $28K | Buy |
+532
| New | +$28K | ﹤0.01% | 297 |
|